We are live on
!
Find out more
Rocket Pharmaceuticals Warrant
RCKTW
RCKTW
15 hedge funds and large institutions have $2.01M invested in Rocket Pharmaceuticals Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
7% more funds holding
Funds holding: 14 → 15 (+1)
0.85% more ownership
Funds ownership: 2.79% → 3.64% (+0.85%)
16% less capital invested
Capital invested by funds: $2.38M → $2.01M (-$372K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACM
Altium Capital Management
New York
|
+$232K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$31 |
Top Sellers
| 1 |
SM
Skaana Management
Brooklyn,
New York
|
-$11.4K |
| 2 |
CAC
Cowen and Company
New York
|
-$823 |
| 3 |
Walleye Capital
New York
|
-$5 |